We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

1 hedge funds and large institutions have $52K invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 297 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 298 → 1 (-297)

100% less funds holding in top 10

Funds holding in top 10: 47 → 0 (-47)

100% less capital invested

Capital invested by funds: $10.8B → $52K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 297

Holders
1
Holders Change
-297
Holders Change %
-99.66%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-47
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
297
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
-$950M
2
PCM
Pentwater Capital Management
Florida
-$652M
3
State Street
State Street
Massachusetts
-$376M
4
YCMGA
York Capital Management Global Advisors
New York
-$327M
5
BIT
BlackRock Institutional Trust
California
-$317M
Name Holding Trade Value Shares
Change 		Change in
Stake
DKCM
26
Davidson Kempner Capital Management
New York
– -$112M -650,536 Closed
AA
27
AQR Arbitrage
Connecticut
– -$111M -641,251 Closed
Franklin Resources
28
Franklin Resources
California
– -$106M -611,722 Closed
EPCM
29
Eton Park Capital Management
New York
– -$105M -607,983 Closed
JHIU
30
Janus Henderson Investors US
Colorado
– -$102M -590,337 Closed
Adage Capital Partners
31
Adage Capital Partners
Massachusetts
– -$95M -550,000 Closed
ACPU
32
Arrowgrass Capital Partners (US)
Delaware
– -$91.5M -529,685 Closed
MF
33
Magnetar Financial
Illinois
– -$89.3M -516,897 Closed
Group One Trading
34
Group One Trading
Illinois
– -$89.2M -516,177 Closed
Norges Bank
35
Norges Bank
Norway
– -$88.7M -513,519 Closed
Northern Trust
36
Northern Trust
Illinois
– -$88.6M -512,868 Closed
JCI
37
Jet Capital Investors
New York
– -$86.4M -500,000 Closed
First Eagle Investment Management
38
First Eagle Investment Management
New York
– -$82.9M -479,891 Closed
BHMP
39
Bardin Hill Management Partners
New York
– -$81.7M -472,550 Closed
GI
40
GAMCO Investors
Connecticut
– -$76.4M -442,350 Closed
JP Morgan Chase
41
JP Morgan Chase
New York
– -$76.1M -440,180 Closed
CPM
42
Chesapeake Partners Management
Maryland
– -$74.2M -429,609 Closed
Alyeska Investment Group
43
Alyeska Investment Group
Illinois
– -$69.1M -399,771 Closed
SM
44
Scoggin Management
New York
– -$66.5M -385,000 Closed
CC
45
Carlson Capital
Texas
– -$66M -382,000 Closed
T
46
TOBAM
France
– -$65.8M -380,611 Closed
Ameriprise
47
Ameriprise
Minnesota
– -$63.6M -367,887 Closed
TCIM
48
TIAA CREF Investment Management
New York
– -$63.5M -367,693 Closed
DLPIC
49
Davide Leone & Partners Investment Company
United Kingdom
– -$62.9M -363,779 Closed
HCM
50
Hoplite Capital Management
New York
– -$62.2M -359,850 Closed
1
2
3 4 5

SLXP Hedge Fund Activity: Q2 2015 in Review

1 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2015, worth a combined $52K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 297 funds closed out of SLXP and 0 opened new positions — a net loss of 297 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Paulson & Co, exiting entirely with an estimated $950M sold.

  • 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2015, down from 298 in Q1 2015.
  • Funds reported $52K of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2015 and 297 closed out, a net change of -297 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q2 2015 was Paulson & Co, an estimated $950M sold.

Based on aggregated 13F filings for Q2 2015.